Grifols SA (GRFS, $6.43) was a top loser over the last three months, falling -2 to $6.43 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry for the 3-month period ending April 30, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.